$63.16 2.6%
EXAS Stock Price vs. AI Score
Data gathered: December 12

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Exact Sciences (EXAS)

Analysis generated November 11, 2024. Powered by Chat GPT.

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of various types of cancer. The company’s flagship product, Cologuard, is a non-invasive stool-based DNA test for colorectal cancer. With a mission to detect cancer early and eradicate it, Exact Sciences has been at the forefront of medical technology in cancer screening. The company has a promising pipeline of diagnostic tests for various types of cancer and aims to continually innovate in the field of medical diagnostics.

Read full AI stock Analysis

Stock Alerts - Exact Sciences (EXAS)

company logo Exact Sciences | December 8
AI Score is down by 20.3% in the last couple of days.
company logo Exact Sciences | December 4
Price is up by 5.4% in the last 24h.
company logo Exact Sciences | November 26
Price is up by 8.3% in the last 24h.
company logo Exact Sciences | November 19
Price is up by 5.2% in the last 24h.

About Exact Sciences

Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers.


Exact Sciences
Price $63.16
Target Price Sign up
Volume 1,770,000
Market Cap $11.7B
Year Range $41.33 - $74.26
Dividend Yield 0%
Analyst Rating 100% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24699M196M503M-38M-11M-0.210
Q2 '24699M190M510M-16M11M-0.090
Q1 '24630M170M459M-110M-84M-0.600
Q4 '233.15B172M2.98B-50M-7.9M-0.270
Q3 '23620M169M452M790,00025M0.004

Insider Transactions View All

Conroy Kevin T filed to buy 1,074,191 shares at $51.4.
November 13 '24
Baranick Brian filed to sell 12,758 shares at $70.
October 9 '24
Baranick Brian filed to sell 13,687 shares at $70.
September 19 '24
Herriott James filed to sell 9,866 shares at $60.2.
May 2 '24
COWARD D SCOTT filed to sell 44,644 shares at $60.2.
May 2 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Democrat
Jun 8, 24 Sell $1K - $15K
Joshua Gottheimer
Democrat
Mar 7, 24 Sell $1K - $15K
Kevin Hern
Republican
Feb 11, 24 Sell $1K - $15K

What is the Market Cap of Exact Sciences?

The Market Cap of Exact Sciences is $11.7B.

What is the current stock price of Exact Sciences?

Currently, the price of one share of Exact Sciences stock is $63.16.

How can I analyze the EXAS stock price chart for investment decisions?

The EXAS stock price chart above provides a comprehensive visual representation of Exact Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Exact Sciences shares. Our platform offers an up-to-date EXAS stock price chart, along with technical data analysis and alternative data insights.

Does EXAS offer dividends to its shareholders?

As of our latest update, Exact Sciences (EXAS) does not offer dividends to its shareholders. Investors interested in Exact Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Exact Sciences?

Some of the similar stocks of Exact Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.